Beating the Resistance
Should we target minor rather than major infections with new therapeutics to best fight antibiotic resistance?
William Aryitey |
An oft-suggested solution to antibiotic resistance is to curb prescriptions for relatively small infections, but this only solves half the problem, as patients still have to deal with minor infections – before they turn into major ones. The current fight against antibiotic resistance revolves around alternative therapeutics for the most severe diseases, but these are difficult to develop. A recent study suggests that alternative therapeutics for minor bacterial infections may be a better solution to help reduce microbes’ growing drug resistance (1).
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Translational Scientist’s entire content archive. It’s FREE and always will be!